Ramipril and Enablex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ramipril (ramipril) and Enablex (darifenacin hydrobromide). Common drug interactions include asphyxia among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Ramipril and Enablex. It is created by eHealthMe based on reports of 100 people who take the same drugs from the FDA, and is updated regularly.

What is Ramipril?

Ramipril has active ingredients of ramipril. It is often used in high blood pressure. eHealthMe is studying from 147,397 Ramipril users. Check the latest studies of Ramipril.

What is Enablex?

Enablex has active ingredients of darifenacin hydrobromide. It is often used in urge incontinence. eHealthMe is studying from 4,934 Enablex users. Check the latest studies of Enablex.

On Jul, 03, 2026

100 people who take Ramipril and Enablex together, and have interactions are studied.

What are the common drug interactions of Ramipril and Enablex, by gender? *:

female:

Asphyxia (a condition in which there is an extreme decrease in the concentration of oxygen in the body)
Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
Death
Arteriosclerosis (thickening and hardening of arteries)
Urticaria (rash of round, red welts on the skin that itch intensely)
Injection site bruising
Muscle spasms (muscle contraction)
Asthenia (weakness)
Abdominal pain upper
Blood pressure systolic increased

male:

Anaemia (lack of blood)
Anorectal disorder
Flushing (the warm, red condition of human skin)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Hypotension (abnormally low blood pressure)
Nodule (a growth of abnormal tissue)
Pruritus (severe itching of the skin)
Psoriasis (immune-mediated disease that affects the skin)
Pyrexia (fever)
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)

What are the common drug interactions of Ramipril and Enablex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Abnormal sensation in eye
Anaemia (lack of blood)
Arthralgia (joint pain)
Blood creatinine increased
Contusion (a type of hematoma of tissue in which capillaries)
Dizziness
Drug ineffective
Fatigue (feeling of tiredness)
Hypotension (abnormally low blood pressure)
Nodule (a growth of abnormal tissue)

60+:

Asphyxia (a condition in which there is an extreme decrease in the concentration of oxygen in the body)
Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
Body temperature decreased
Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
Diarrhoea
Drug hypersensitivity
Influenza
Injection site mass
Injection site pain
Irritable bowel syndrome

What are the existing conditions these people have? *

Pain: 17 people, 17.00%
Bladder Disorder: 15 people, 15.00%
Joint Pain: 14 people, 14.00%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 14 people, 14.00%
Cardiac Disorder: 14 people, 14.00%
Urticaria (rash of round, red welts on the skin that itch intensely): 10 people, 10.00%
High Blood Cholesterol: 7 people, 7.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ramipril and Enablex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously